302 related articles for article (PubMed ID: 23134201)
1. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
2. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
3. Xanthogranulomatous cholecystitis: a premalignant condition?
Ghosh M; Sakhuja P; Agarwal AK
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):179-84. PubMed ID: 21459725
[TBL] [Abstract][Full Text] [Related]
4. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S
Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of xanthogranulomatous cholecystitis: precancerous lesion of gallbladder cancer?
Takada M; Horita Y; Okuda S; Okumoto S; Samizo M; Wada T; Kuroda Y; Maeda S
Hepatogastroenterology; 2002; 49(46):935-7. PubMed ID: 12143246
[TBL] [Abstract][Full Text] [Related]
7. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.
Rao RV; Kumar A; Sikora SS; Saxena R; Kapoor VK
Trop Gastroenterol; 2005; 26(1):31-3. PubMed ID: 15974235
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive preoperative differential diagnosis of gallbladder carcinoma and xanthogranulomatous cholecystitis: A retrospective cohort study of 240 patients.
Xiao J; Zhou R; Zhang B; Li B
Cancer Med; 2022 Jan; 11(1):176-182. PubMed ID: 34837350
[TBL] [Abstract][Full Text] [Related]
9. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
[TBL] [Abstract][Full Text] [Related]
10. Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5.
Yu H; Yu TN; Cai XJ
Chin Med J (Engl); 2013 Aug; 126(16):3044-7. PubMed ID: 23981609
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.
Takahashi T; Shivapurkar N; Riquelme E; Shigematsu H; Reddy J; Suzuki M; Miyajima K; Zhou X; Bekele BN; Gazdar AF; Wistuba II
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6126-33. PubMed ID: 15447999
[TBL] [Abstract][Full Text] [Related]
13. Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer.
Suzuki H; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
World J Gastroenterol; 2015 Sep; 21(35):10166-73. PubMed ID: 26401081
[TBL] [Abstract][Full Text] [Related]
14. Lipid profiling of cancerous and benign gallbladder tissues by 1H NMR spectroscopy.
Jayalakshmi K; Sonkar K; Behari A; Kapoor VK; Sinha N
NMR Biomed; 2011 May; 24(4):335-42. PubMed ID: 22945290
[TBL] [Abstract][Full Text] [Related]
15. Xanthogranulomatous cholecystitis (XGC): a clinicopathological study of 21 cases.
Solanki RL; Arora HL; Gaur SK; Anand VK; Gupta R
Indian J Pathol Microbiol; 1989 Oct; 32(4):256-60. PubMed ID: 2632411
[TBL] [Abstract][Full Text] [Related]
16. Role of E-cadherin gene in gall bladder cancer and its precursor lesions.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agrawal S
Virchows Arch; 2010 May; 456(5):507-14. PubMed ID: 20376482
[TBL] [Abstract][Full Text] [Related]
17. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: An analysis of 42 cases.
Deng YL; Cheng NS; Zhang SJ; Ma WJ; Shrestha A; Li FY; Xu FL; Zhao LS
World J Gastroenterol; 2015 Nov; 21(44):12653-9. PubMed ID: 26640342
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-pathological study of xanthogranulomatous cholecystitis].
Kitagawa S; Nakagawa M; Yamada T; Mori Y; Simizu H; Rin S; Kurumaya H
Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1001-10. PubMed ID: 2233654
[TBL] [Abstract][Full Text] [Related]
19. Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer.
Agarwal AK; Kalayarasan R; Javed A; Sakhuja P
J Gastrointest Surg; 2013 Jul; 17(7):1257-64. PubMed ID: 23615807
[TBL] [Abstract][Full Text] [Related]
20. Is xanthogranulomatous cholecystitis the most difficult for laparoscopic cholecystectomy?
Kim JH; Jeong IH; Yoo BM; Kim JH; Kim MW; Kim WH
Hepatogastroenterology; 2009; 56(91-92):597-601. PubMed ID: 19621662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
